CER-001, an Engineered High-Density Lipoprotein, Shows Beneficial Pleiotropic Effects in Patients with Sepsis in RACERS: A Phase 2A Randomized Control Trial

human recombinant apoA-I/sphingomyelin/dipalmitoylphosphatidylglycerol (CER-001) - Abionyx Pharma

Marco Fiorentino1; Alessandra Stasi1; Rossana Franzin1; Loreto Gesualdo1

Oct 15, 2023